Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

"The laser beam can be positioned with great accuracy on surfaces, so we can produce significantly smaller microlenses than is possible with previously existing methods," commented Thomas Höche head ...